Company: AEMD
Filing Date: 2025-08-29
Form Type: S-1/A
Source: 0001683168-25-006537
Chunk: 49

Company: AETHLON MEDICAL INC
Filing Date: 2025-08-29
Form: S-1/A
Chunk 49
---
 the Inducement Warrants in order to permit the Selling Securityholders to offer the shares of common stock
for resale from time to time. The registration of such common stock does not necessarily mean, however, that any of the shares of common
stock will be offered or sold by the Selling Securityholders. We will not receive any proceeds from the sale of the common stock by the
Selling Securityholders, and we have borne and will continue to bear the costs relating to the registration of these shares of common
stock, other than commissions and discounts of agents or broker-dealers and transfer taxes, if any.

The Inducement Warrants held by
the Selling Securityholders contain limitations which prevent the holder from exercising those Inducement Warrants if such exercise or
conversion would cause the Selling Securityholders, together with certain related parties, to beneficially own a number of shares of common
stock which would exceed 4.99% of our then outstanding common stock following such exercise or conversion, excluding for purposes of such
determination, common stock issuable upon exercise of the Inducement Warrants which have not been exercised.

The table below sets forth,
as of August 21, 2025, the following information regarding the Selling Securityholders:

| · | the name of the Selling                                                                                                               
 Securityholders;                                                                                                                      |
| · | the number of shares                                                                                                                  
 of common stock owned by the Selling Securityholders prior to this offering, without regard to any beneficial ownership limitations   
 contained in the Inducement Warrants;                                                                                                 |
| · | the number of shares                                                                                                                  
 of common stock to be offered by the Selling Securityholders in this offering;                                                        |
| · | the number of shares                                                                                                                  
 of common stock to be owned by the Selling Securityholders assuming the sale of all of the shares of common stock covered by this     
 prospectus; and                                                                                                                       |
| · | the percentage of our                                                                                                                 
 issued and outstanding shares of common stock to be owned by the Selling Securityholders assuming the sale of all of the common stock 
 covered by this prospectus based on the number of shares of common stock issued and outstanding as of August 21, 2025.                |

Except as described above,
the number of shares of common stock beneficially owned by the Selling Securityholders have been determined in accordance with Rule 13d-3
under the Exchange Act and includes, for such purpose, shares of common stock that the Selling Securityholders have the right to acquire
within 60